To further validate our finding, we included RNA-seq datasets (Curie cohort and Gustave Roussy cohort) (24) of SCCOHTs (n = 11), SMARCB1-deficient atypical teratoid/rhabdoid tumors (ATRTs; n = 38), SMARCB1-deficient extracranial rhabdoid tumors (ECRT-SMARCB1; n = 19), and SMARCA4-deficient extracranial rhaboid tumors (ECRT-SMARCA4; n = 4) in our transcriptomic analysis. The gene discussed is SMARCB1; the disease is rhabdoid tumor.